BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 19558547)

  • 21. Methylated-(3'')-epigallocatechin gallate analog suppresses tumor growth in Huh7 hepatoma cells via inhibition of angiogenesis.
    Hashimoto O; Nakamura A; Nakamura T; Iwamoto H; Hiroshi M; Inoue K; Torimura T; Ueno T; Sata M
    Nutr Cancer; 2014; 66(4):728-35. PubMed ID: 24033329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The epigallocatechin gallate derivative Y6 reduces the cardiotoxicity and enhances the efficacy of daunorubicin against human hepatocellular carcinoma by inhibiting carbonyl reductase 1 expression.
    Zhou H; Fu LX; Li L; Chen YY; Zhu HQ; Zhou JL; Lv MX; Gan RZ; Zhang XX; Liang G
    J Ethnopharmacol; 2020 Oct; 261():113118. PubMed ID: 32621953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory effects of epigallocatechin-3 gallate, a polyphenol in green tea, on tumor-associated endothelial cells and endothelial progenitor cells.
    Ohga N; Hida K; Hida Y; Muraki C; Tsuchiya K; Matsuda K; Ohiro Y; Totsuka Y; Shindoh M
    Cancer Sci; 2009 Oct; 100(10):1963-70. PubMed ID: 19650861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. (-)-Epigallocatechin-3-gallate inhibits human papillomavirus (HPV)-16 oncoprotein-induced angiogenesis in non-small cell lung cancer cells by targeting HIF-1α.
    He L; Zhang E; Shi J; Li X; Zhou K; Zhang Q; Le AD; Tang X
    Cancer Chemother Pharmacol; 2013 Mar; 71(3):713-25. PubMed ID: 23292117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PPemd26, an anthraquinone derivative, suppresses angiogenesis via inhibiting VEGFR2 signalling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Br J Pharmacol; 2014 Dec; 171(24):5728-42. PubMed ID: 25091695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells.
    Jung YD; Kim MS; Shin BA; Chay KO; Ahn BW; Liu W; Bucana CD; Gallick GE; Ellis LM
    Br J Cancer; 2001 Mar; 84(6):844-50. PubMed ID: 11259102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular mechanism of epigallocatechin-3-gallate in human esophageal squamous cell carcinoma in vitro and in vivo.
    Liu L; Hou L; Gu S; Zuo X; Meng D; Luo M; Zhang X; Huang S; Zhao X
    Oncol Rep; 2015 Jan; 33(1):297-303. PubMed ID: 25333353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Green tea catechin, epigallocatechin-3-gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex.
    Rodriguez SK; Guo W; Liu L; Band MA; Paulson EK; Meydani M
    Int J Cancer; 2006 Apr; 118(7):1635-44. PubMed ID: 16217757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different cascades in the signaling pathway of two vascular endothelial growth factor (VEGF) receptors for the VEGF-mediated murine hepatocellular carcinoma development.
    Yoshiji H; Noguchi R; Kuriyama S; Yoshii J; Ikenaka Y; Yanase K; Namisaki T; Kitade M; Yamazaki M; Uemura M; Fukui H
    Oncol Rep; 2005 May; 13(5):853-7. PubMed ID: 15809749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of VEGF165/VEGFR2-dependent signaling by LECT2 suppresses hepatocellular carcinoma angiogenesis.
    Chen CK; Yu WH; Cheng TY; Chen MW; Su CY; Yang YC; Kuo TC; Lin MT; Huang YC; Hsiao M; Hua KT; Hung MC; Kuo ML
    Sci Rep; 2016 Aug; 6():31398. PubMed ID: 27507763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting receptor tyrosine kinases for chemoprevention by green tea catechin, EGCG.
    Shimizu M; Shirakami Y; Moriwaki H
    Int J Mol Sci; 2008 Jun; 9(6):1034-1049. PubMed ID: 19325845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Epigallocatechin-3-gallate inhibits growth and angiogenesis of gastric cancer and its molecular mechanism].
    Zhu BH; Zhan WH; He YL; Cai SR; Wang Z; Zhang CH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Jan; 12(1):82-5. PubMed ID: 19145512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epigallocatechin-3-gallate inhibits the PDGF-induced VEGF expression in human vascular smooth muscle cells via blocking PDGF receptor and Erk-1/2.
    Park JS; Kim MH; Chang HJ; Kim KM; Kim SM; Shin BA; Ahn BW; Jung YD
    Int J Oncol; 2006 Nov; 29(5):1247-52. PubMed ID: 17016658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Green tea component epigallocatechin-3-gallate decreases expression of osteopontin via a decrease in mRNA half-life in cell lines of metastatic hepatocellular carcinoma.
    Zapf MA; Kothari AN; Weber CE; Arffa ML; Wai PY; Driver J; Gupta GN; Kuo PC; Mi Z
    Surgery; 2015 Oct; 158(4):1039-47; discussion 1047-8. PubMed ID: 26189955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The green tea compound, (-)-epigallocatechin-3-gallate downregulates N-cadherin and suppresses migration of bladder carcinoma cells.
    Rieger-Christ KM; Hanley R; Lodowsky C; Bernier T; Vemulapalli P; Roth M; Kim J; Yee AS; Le SM; Marie PJ; Libertino JA; Summerhayes IC
    J Cell Biochem; 2007 Oct; 102(2):377-88. PubMed ID: 17348027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostanoid EP1 receptor as the target of (-)-epigallocatechin-3-gallate in suppressing hepatocellular carcinoma cells in vitro.
    Jin J; Chang Y; Wei W; He YF; Hu SS; Wang D; Wu YJ
    Acta Pharmacol Sin; 2012 May; 33(5):701-9. PubMed ID: 22555372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apatinib targets both tumor and endothelial cells in hepatocellular carcinoma.
    Yang C; Qin S
    Cancer Med; 2018 Sep; 7(9):4570-4583. PubMed ID: 30109780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigallocatechin-3-gallate inhibits epidermal growth factor receptor signaling pathway. Evidence for direct inhibition of ERK1/2 and AKT kinases.
    Sah JF; Balasubramanian S; Eckert RL; Rorke EA
    J Biol Chem; 2004 Mar; 279(13):12755-62. PubMed ID: 14701854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Foretinib inhibits angiogenesis, lymphangiogenesis and tumor growth of pancreatic cancer in vivo by decreasing VEGFR-2/3 and TIE-2 signaling.
    Chen HM; Tsai CH; Hung WC
    Oncotarget; 2015 Jun; 6(17):14940-52. PubMed ID: 25909285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The vascular endothelial growth factor receptor (VEGFR-1) supports growth and survival of human breast carcinoma.
    Wu Y; Hooper AT; Zhong Z; Witte L; Bohlen P; Rafii S; Hicklin DJ
    Int J Cancer; 2006 Oct; 119(7):1519-29. PubMed ID: 16671089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.